<?xml version="1.0" encoding="UTF-8"?>
<ref id="B43">
 <label>43</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bocci</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Valacchi</surname>
    <given-names>G</given-names>
   </name>
  </person-group>
  <article-title>Nrf2 activation as target to implement therapeutic treatments</article-title>. 
  <source>Front Chem</source> (
  <year>2015</year>) 
  <volume>3</volume>:
  <elocation-id>4</elocation-id>. Â 
  <pub-id pub-id-type="doi">10.3389/fchem.2015.00004</pub-id>
  <pub-id pub-id-type="pmid">25699252</pub-id>
 </mixed-citation>
</ref>
